Atlantic Sapphire's Bridge Loan Could Force Shareholder Squeeze as Debt-Equity Swap Looms

Atlantic Sapphire is caught in a stark conflict between immediate survival and long-term value. The company has revised its near-term funding need upward to $25–30 million to maintain sufficient liquidity and reach EBITDA break-even. This is an increase from earlier estimates and creates a hard deadline: the company warns it would fall into technical default under its loan agreements by March 31, 2026 if this cash isn't secured.

Against this backdrop, a proposed $10 million bridge loan has been offered by a group of existing shareholders and lenders. The terms are steep, carrying 12% annual interest and a 15% origination fee. The loan would be released in two tranches, with the first potentially available around March 30, and would run until mid-May unless a longer-term deal is found. This offer is being evaluated alongside a separate, higher-priced takeover proposal from the same controlling group, which holds 63% of the shares and 93% of the convertible debt.

The tension is clear. The bridge loan addresses the urgent cash crunch but at a high cost that will further dilute shareholders. The takeover offer, while potentially more expensive, represents a different path-one that could resolve the capital structure crisis but at a price that may not reflect the company's operational progress. The company's own advisers have valued the business at between $25 million and $75 million, a range that sits well below its total debt exceeding $114 million. This disconnect between a modest operational valuation and massive debt obligations is the core of the crisis.

Operational Reality and Financial Pressure

The company's operational progress is real but not yet profitable. Atlantic Sapphire posted revenue of USD 21.5 million in H1 2025, nearly doubling the prior-year period. Yet this growth has not translated to earnings; the company's EBITDA increased to a loss of USD 30.7 million for the same half, a significant improvement from the $46.6 million loss in H1 2024. This widening loss despite revenue growth highlights the intense cost pressures the business faces.

The target for turning this around is clear. Management's goal is to achieve EBITDA break-even at its operating facility. The Phase 1 facility in Florida has an annual harvest capacity of approximately 7,500–8,500 tonnes. The company's revised funding need of $25–30 million is explicitly tied to reaching this break-even point at that operating level. The math here is straightforward: the company needs a substantial cash infusion to cover the gap between its current losses and the point where its operations can cover their own costs.

A delay in financial transparency adds to the pressure. The company has postponed the publication of its annual financial accounts for the year ended 31 December 2025, moving the release date from April 23 to April 30, 2026. This extension is linked to ongoing financing negotiations, creating a period where critical financial details are withheld. For investors and potential lenders, this lack of timely, audited information makes it harder to assess the true financial health and the feasibility of the break-even target, potentially increasing the perceived risk and cost of any capital provided.

The Restructuring Path: Dilution and Control

The proposed bridge loan is not a standalone fix but the first step in a comprehensive restructuring plan that will dramatically reshape the company. The broader deal, as outlined by the company, hinges on converting a massive portion of its debt into equity. This process, known as "equitization," is the engine of the plan and the primary source of future dilution. The Investor Group, which controls the bridge loan, has indicated it would write off part of what they are owed and convert the rest into shares. The plan details that the Investor Group would agree to write off 23% of their 93% of the Convertible Loan and convert the remainder into shares at a price of NOK 0.1 per share. This conversion of debt into equity is a direct mechanism for reducing the company's crippling debt load, but it simultaneously floods the share register with new stock, diluting the ownership stakes of all existing shareholders.

This dilution is compounded by the plan's other components. Following a voluntary tender offer, the company would conduct a rights issue at a per share subscription price of NOK 0.1 to raise additional capital. The bridge loan itself would also be converted into shares at that same low price. The result is a multi-pronged effort to inject new equity at a deeply discounted rate, which will inevitably lead to substantial dilution for current owners. The company itself has acknowledged that these steps would result in significant changes to the Company's capital structure, substantial dilution and could lead to a compulsory acquisition of existing shareholders.

The Investor Group's control is the key to this entire process. They represent approximately 63% of the shares and 93% of the Company's outstanding convertible loan. This dominant position gives them immense leverage to push through the restructuring on their terms. Their ability to write off a portion of their own debt and convert the rest at a bargain price is a direct function of their control. This concentration of power means the outcome of the refinancing is not a neutral negotiation but a plan being driven by a controlling bloc.

The plan's final, most consequential element is the potential for a compulsory acquisition. The voluntary tender offer, priced at NOK 0.5 per share, is structured to meet the legal requirements for a mandatory offer. If the offer is successful and the Investor Group acquires a controlling stake, the company could be taken private. This would trigger a compulsory acquisition of existing shareholders, forcing minority owners to sell their shares at the tender offer price. This mechanism ensures that the controlling group can consolidate ownership and finalize the restructuring, but it does so at a price that is a fraction of the company's current market value and far below the $25–75 million valuation range cited by its own advisers. The path forward is clear: a high-cost bridge loan leads to a debt-for-equity swap, massive dilution, and a potential squeeze-out of minority investors.

Catalysts, Risks, and What to Watch

The immediate future for Atlantic Sapphire hinges on a series of interconnected events, each carrying significant weight for the company's survival and the fate of its shareholders. The primary catalyst is securing a longer-term financing solution by mid-May to replace the bridge loan and fund operations to the critical EBITDA break-even point. The company's revised funding target of $25–30 million is the benchmark for this success. Without a deal in place by the bridge loan's maturity on May 15, the company faces technical default, making the next six weeks a period of intense negotiation and execution.

A major risk is that the dilution and control changes required for the restructuring may not attract sufficient new capital or could face shareholder opposition. The plan's core mechanism-converting debt into shares at a price of NOK 0.1-represents a massive write-down for lenders and a severe dilution for existing owners. While the controlling Investor Group has the power to push through the plan, the success of the broader refinancing depends on convincing other stakeholders that the revised capital structure is viable. The company's own advisers have valued the business at between $25 million and $75 million, a range that sits well below its total debt exceeding $114 million. This valuation disconnect raises questions about the plan's ability to attract fresh investment at a meaningful price, especially if the market perceives the equity being offered as deeply discounted.

Investors should monitor three key developments in the coming weeks. First, the finalization of the bridge loan terms and the disbursement of the first tranche around March 30 are the immediate tests of the plan's viability. Second, progress on the comprehensive refinancing, including the voluntary tender offer and the rights issue, will reveal the level of support for the restructuring. Third, and most critically, the company's ability to meet its revised $25–30 million funding target will determine whether the bridge loan can be replaced and operations can continue toward break-even. The delay in publishing its annual accounts until April 30 further obscures the financial picture during this crucial period, increasing uncertainty for all parties involved.